Sarah Karlin-Smith of Pink Sheet reported via X: “RFK says HHS about to launch one of the biggest campaigns in HHS history to encourage Americans to use wearable health devices (like CGMs). His vision is every American wearing “wearable” in 4 years.” Shares of companies in the continuous glucose monitoring space moved higher intraday, including Tandem Diabetes (TNDM), DexCom (DXCM), Insulet (PODD), Abbott (ABT) and Medtronic (MDT).

Confident Investing Starts Here:

• Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions

• Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. >;elm:context_link;itc:0;sec:content-canvas" href="https://thefly.com/?utm_source=finance.yahoo.com&utm_medium=referral" rel="nofollow noopener" target="_blank">Try Now>>

>;elm:context_link;itc:0;sec:content-canvas" href="https://www.tipranks.com/screener/top-insider-trading-stocks/?type=stockAnalysisLanding&utm_source=finance.yahoo.com&utm_medium=referral" rel="nofollow noopener" target="_blank">See Insiders’ Hot Stocks on TipRanks >>

Read More on TNDM:

Disclaimer & DisclosureReport an Issue

• Cisco upgraded, CoreWeave downgraded: Wall Street’s top analyst calls

• Tandem Diabetes initiated with a Hold at Truist

• Tandem Diabetes announces agreement with Abbott to develop diabetes solutions

• Tandem Diabetes Care: Strategic Initiatives and Product Launches Drive Long-Term Growth Potential

• Balanced Outlook on Tandem Diabetes Care: Growth Opportunities Amid Strategic Challenges